Online citations, reference lists, and bibliographies.
← Back to Search

Vasoactive Peptide Release In The Extracerebral Circulation Of Humans During Migraine Headache

P. J. Goadsby, L. Edvinsson, R. Ekman
Published 1990 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The innervation of the cranial vessels by the trigeminal nerve, the trigeminovascular system, has recently been the subject of study in view of its possible role in the mediation of some aspects of migraine. Since stimulation of the trigeminal ganglion in humans leads to facial pain and flushing and associated release of powerful neuropeptide vasodilator substances, their local release into the extracerebral circulation of humans was determined in patients who had either common or classic migraine. Venous blood was sampled from both the external jugular and the cubital fossa ipsilateral to the side of headache. Plasma levels of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene‐related peptide were determined using sensitive radioimmunoassays for each peptide, and values for the cubital fossa and external jugular and a control population were compared. A substantial elevation of the calcitonin gene‐related peptide level in the external jugular but not the cubital fossa blood was seen in both classic and common migraine. The increase seen in classic migraine was greater than that seen with common migraine. The other peptides measured were unaltered. This finding may have importance in the pathophysiology of migraine.
This paper references
10.1097/00004872-198900076-00093
Circulating perivascular dilatory neuropeptides in hypertension.
L. Edvinsson (1989)
10.1177/03331024850050S3137
Plasma-VIP and Plasma-Substance-P during Migraine-Attack
N. Blegvad (1985)
10.1136/jnnp.50.5.642
Failure to detect plasma neuropeptide release during trigeminal thermocoagulation.
H. Schon (1987)
10.1136/jnnp.46.7.611
Facial flushing after thermocoagulation of the Gasserian ganglion.
P. Drummond (1983)
10.1111/j.1526-4610.1983.hed2306258.x
Brainstem Influences on the Cephalic Circulation: Experimental Data From Cat and Monkey of Relevance to the Mechanism of Migraine
J. Lance (1983)
10.1212/WNL.30.2.203
Icepick‐like pain
N. Raskin (1980)
10.1046/j.1468-2982.1984.0403149.x
Facial Temperature in Migraine, Tension-Vascular and Tension Headache
P. Drummond (1984)
10.1002/ANA.410120311
Characterization of 5‐hydroxytryptamine receptors in human temporal arteries: Comparison between migraine sufferers and nonsufferers
T. Skärby (1982)
10.1016/0006-8993(83)90402-X
Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats
L. Liu-Chen (1983)
10.1002/ANA.410130108
Extracranial vascular changes and the source of pain in migraine headache
P. Drummond (1983)
10.1016/0167-0115(86)90059-5
Peptide YY-like immunoreactivity in the central nervous system of the rat
R. Ekman (1986)
10.1002/ANA.410230214
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system
P. J. Goadsby (1988)
10.1016/0006-8993(86)90690-6
Stimulation of the Trigeminal ganglion increases flow in the extracerebral but not the cerebral circulation of the monkey
P. Goadsby (1986)
10.1016/S0140-6736(79)92692-8
NEUROTRANSMITTERS AND THE FIFTH CRANIAL NERVE: IS THERE A RELATION TO THE HEADACHE PHASE OF MIGRAINE?
MichaelA. Moskowitz (1979)
10.1111/J.1748-1716.1985.TB07710.X
Changes in oviductal VIP content induced by sex steroids and inhibitory effect of VIP on spontaneous oviductal contractility.
G. Helm (1985)
10.1016/0304-3940(85)90296-4
Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: Trigeminal origin and co-existence with substance P
R. Uddman (1985)
10.1016/0306-4522(83)90268-3
Pia arachnoid contains substance P originating from trigeminal neurons
L. -. Liu-Chen (1983)
10.3171/JNS.1984.61.2.0307
Decreased carotid arterial resistance in cats in response to trigeminal stimulation.
G. Lambert (1984)
10.1046/j.1468-2982.1988.0801001.x
Flunarizine in Prophylaxis of Childhood Migraine: A Double-Blind, Placebo-Controlled, Crossover Study
Fulvio Sorge (1988)
10.1111/j.1526-4610.1976.hed1605222.x
ICE CREAM HEADACHE AND ORTHOSTATIC SYMPTOMS IN PATIENTS WITH MIGRAINE
N. Raskin (1976)
10.1210/ENDO-119-5-2313
Calcitonin gene-related peptide in thyroid nerve fibers and C cells: effects on thyroid hormone secretion and response to hypercalcemia.
T. Grunditz (1986)
10.1111/j.1526-4610.1987.hed2708416.x
Headache May Arise From Perturbation of Brain
N. Raskin (1987)
10.3109/08039488809103218
Possible relationship between neuropeptide Y (NPY) and major depression – evidence from human and animal studies
E. Widerlöv (1988)
10.1016/0006-8993(85)90535-9
Extracranial vasodilatation mediated by vasoactive intestinal polypeptide (VIP)
P. Goadsby (1985)
10.1016/0165-1838(84)90053-5
The peripheral pathway for extracranial vasodilatation in the cat.
P. Goadsby (1984)
10.1016/0167-0115(88)90075-4
Neurokinin A in cerebral vessels: characterization, localization and effects in vitro
L. Edvinsson (1988)



This paper is referenced by
Neurovascular Pharmacology of Prospective Antimigraine Drugs
K. Chan (2011)
10.1007/BF02530381
Calcitonin gene-related peptide immunreaktive Nervenfasern in der Dura mater encephali der Ratte
K. Messlinger (2006)
10.1046/j.1468-2982.1995.015002109.x
Cerebral Blood Flow Velocities are Reduced During Attacks of Unilateral Migraine Without Aura
L. Thomsen (1995)
10.1016/S0143-4179(96)90081-5
NK1 and CGRP receptor-mediated dilatation of the carotid arterial bed of the anaesthetized rabbit
M. Perren (1996)
10.1016/S0167-0115(96)00137-1
The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system
J. Polley (1997)
10.1046/j.1468-2982.1997.1703153.x
Direct Evidence for Central Sites of Action of Zolmitriptan (311C90)
P. Goadsby (1997)
10.1111/j.1526-4610.2005.05135.x
Plasma Cytokine Levels in Migraineurs and Controls
F. Perini (2005)
10.1111/j.1526-4610.2004.04189.x
Chemokine Levels in the Jugular Venous Blood of Migraine Without Aura Patients During Attacks
P. Sarchielli (2004)
10.1111/j.1526-4610.2008.01205.x
Role of KATP Channels in Cephalic Vasodilatation Induced by Calcitonin Gene‐Related Peptide, Nitric Oxide, and Transcranial Electrical Stimulation in the Rat
A. Gozalov (2008)
10.1016/S0306-4522(98)00366-2
Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro
A. Ebersberger (1999)
10.1016/S0006-8993(03)02975-5
Stress-induced dura vascular permeability does not develop in mast cell-deficient and neurokinin-1 receptor knockout mice
Kristiana Kandere-Grzybowska (2003)
10.2217/14796708.1.2.171
New targets in acute migraine treatment
P. Goadsby (2006)
10.1111/j.1468-2982.2005.01076.x
Prevalence of Unexplained Upper Abdominal Symptoms in Patients with Migraine
T. Kurth (2006)
10.1007/978-3-211-69357-5_3
Migräne und andere Kopfschmerzen
G. Sixt (2007)
10.1007/s10072-007-0772-6
The future of acute care and prevention in headache
A. Krymchantowski (2007)
10.2217/14622416.8.7.687
Ramping it up: RAMP1 and the implications for migraine.
A. Russo (2007)
Calcitonin gene-related peptide receptor antagonists for the treatment of migraine: a patent
Daniel V. Paone (2009)
Recurrent Spontaneous Vertigo: Diagnosis
이승한 (2012)
10.1046/j.1526-4610.2000.00022.x
Montelukast in the Prophylaxis of Migraine: A Potential Role for Leukotriene Modifiers
F. Sheftell (2000)
10.1038/sj.bjp.0705768
Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function
P. Geppetti (2004)
10.1111/cts.12728
Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult Males
W. Ankrom (2020)
10.1002/cne.21607
Calcitonin receptor‐like receptor (CLR), receptor activity‐modifying protein 1 (RAMP1), and calcitonin gene‐related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution
J. K. Lennerz (2008)
10.1007/s10194-010-0260-x
Neurogenic inflammation: a study of rat trigeminal ganglion
K. A. Kristiansen (2010)
10.1111/head.13907
Efficacy and Contextual (Placebo) Effects of CGRP Antibodies for Migraine: Systematic Review and Meta‐analysis
R. Forbes (2020)
10.1016/S0304-3959(99)00159-1
Plasma levels of substance P, neuropeptide Y and vasoactive intestinal polypeptide in patients with chronic tension-type headache
M. Ashina (1999)
10.1002/1531-8249(200101)49:1<4::AID-ANA3>3.0.CO;2-W
Migraine, aura, and cortical spreading depression: Why are we still talking about it?
P. Goadsby (2001)
10.1016/S0196-9781(01)00408-9
Neuronal messengers in the human cerebral circulation
S. Gulbenkian (2001)
10.1046/J.1468-2982.2002.00304.X
Increased Plasma Nitrites in Migraine and Cluster Headache Patients in Interictal Period: Basal Hyperactivity of L-Arginine-No Pathway?
D. D’amico (2002)
10.1046/j.1468-2982.2003.00553.x
Nitric Oxide Pathway and Response to Nitroglycerin in Cluster Headache Patients: Plasma Nitrite and Citrulline Levels
A. Costa (2003)
10.1177/0333102416639517
Part II: Biochemical changes after pituitary adenylate cyclase-activating polypeptide-38 infusion in migraine patients
Song Guo (2017)
10.1097/j.pain.0000000000001858
PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?
J. Hoffmann (2020)
10.1016/j.nurpra.2019.07.009
Monoclonal Antibodies to CGRP or Its Receptor for Migraine Prevention
Maureen Moriarty (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar